LUCCHESI, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 378
EU - Europa 132
AS - Asia 119
SA - Sud America 21
AF - Africa 9
Totale 659
Nazione #
US - Stati Uniti d'America 372
IT - Italia 69
SG - Singapore 39
CN - Cina 35
BR - Brasile 20
HK - Hong Kong 19
SE - Svezia 15
GB - Regno Unito 13
DE - Germania 9
VN - Vietnam 9
BG - Bulgaria 7
CI - Costa d'Avorio 6
CA - Canada 5
FR - Francia 5
IN - India 5
FI - Finlandia 4
RU - Federazione Russa 3
BD - Bangladesh 2
CH - Svizzera 2
ES - Italia 2
PK - Pakistan 2
TR - Turchia 2
AR - Argentina 1
IL - Israele 1
JM - Giamaica 1
JP - Giappone 1
KE - Kenya 1
LB - Libano 1
LY - Libia 1
NL - Olanda 1
PH - Filippine 1
PL - Polonia 1
TW - Taiwan 1
UA - Ucraina 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 659
Città #
Woodbridge 43
Ashburn 38
Dallas 37
Fairfield 34
Houston 31
San Jose 25
Chandler 20
Serra 20
Hong Kong 17
Singapore 16
Pisa 12
Seattle 12
Santa Clara 11
Wilmington 11
Ann Arbor 10
Beijing 9
Cambridge 9
London 7
New York 7
Sofia 7
Abidjan 6
Florence 6
Shanghai 6
Boardman 4
Dearborn 4
Los Angeles 4
Ottawa 4
Princeton 4
Des Moines 3
Lauterbourg 3
Lawrence 3
Medford 3
Besencens 2
Bremen 2
Buffalo 2
Frankfurt am Main 2
Hanoi 2
Kunming 2
Lancaster 2
Modena 2
Munich 2
Nanjing 2
Orem 2
Phoenix 2
Positano 2
Redwood City 2
Rome 2
Santiago De Compostela 2
São Paulo 2
Andorinha 1
Ankara 1
Araguaína 1
Badin 1
Beirut 1
Boston 1
Brasília 1
Bình Dương 1
Cagliari 1
Catonsville 1
Chicago 1
City of London 1
Dasmariñas 1
Freiburg 1
Glorinha 1
Goiânia 1
Guangzhou 1
Guarulhos 1
Gálvez 1
Hebei 1
Hefei 1
Helsinki 1
Ho Chi Minh City 1
Indiana 1
Istanbul 1
Itajaí 1
Italva 1
Jackson 1
Jacobina 1
Jaipur 1
Johannesburg 1
Karachi 1
Kingston 1
Lucknow 1
Manaus 1
Marengo 1
Massarosa 1
Milan 1
Nairobi 1
Nanchang 1
Nova Friburgo 1
Nuremberg 1
Ogden 1
Paris 1
Pedreira 1
Pedro Velho 1
Pelotas 1
Piracicaba 1
Poplar 1
Porto Alegre 1
Portsmouth 1
Totale 511
Nome #
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 204
Impact of a supportive care service for cancer outpatients: management and reduction of hospitalizations. Preliminary results of an integrated model of care 191
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 150
null 113
Bevacizumab and Paclitaxel in Advanced, Hormone Receptor-Positive Breast Cancer: Multifactor Dimensionality Reduction Methodology to Identify Best Overall Survival 13
Totale 671
Categoria #
all - tutte 1.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.823


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/202231 0 0 0 0 5 7 0 2 3 1 3 10
2022/202364 6 10 4 3 9 6 0 2 14 2 8 0
2023/202428 0 1 3 2 3 7 2 4 1 0 2 3
2024/2025116 0 3 0 8 9 16 5 5 14 21 11 24
2025/2026157 13 22 26 12 12 11 19 6 5 9 20 2
Totale 671